Atlas Trials

Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma

Clinical trial NCT02897830 · TERMINATED

Trial details

NCT number
NCT02897830
Sponsor
University Hospital, Toulouse
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2016-08-05
Primary completion
2018-11-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.